BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Cancer Genetics is Among the First To Drive New FDA-Approved Testing Paradigm for Non-Small Cell Lung Cancer Patients by Offering Thermo Fisher Scientific’s Oncomine Dx Target Test

  November 2, 2017

   · 

  5 min read
• Business

  VBI Vaccines Strengthens Board of Directors With Appointment of Ran Nussbaum

  “We are honored to have Ran join our Board of Directors,” said Jeff Baxter, VBI’s president and CEO.

  November 2, 2017

   · 

  5 min read
• Business

  Progenics Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Update

  Third quarter revenue totaled $2.7 million, down from $53.9 million in the third quarter of 2016, reflecting RELISTOR royalty income of $2.6 million compared to $3.3 million in the corresponding period of 2016.

  November 2, 2017

   · 

  13 min read
• Deals

  Teva Announces Completion of Plan B One-Step Divestiture to Foundation Consumer Healthcare

  Teva to receive $675 million cash proceeds to progress repayment of term loan debt.

  November 2, 2017

   · 

  6 min read
• BioMidwest

  Myriad Announces GeneSight Psychotropic Results From a Large Prospective Trial in Patients With Major Depressive Disorder

  This was the largest ever pharmacogenomics depression trial and primarily assessed Hamilton Depression Rating Scale 17 (HAMD-17) scores from baseline to eight weeks in patients receiving GeneSight-guided therapy compared to those receiving treatment-as-usual.

  November 2, 2017

   · 

  9 min read
• Policy

  Galapagos Moving Forward in CF Programs at NACFC 2017

  Ten posters and four oral presentations reflect progress toward triple combination therapy.

  November 2, 2017

   · 

  5 min read
• Business

  GN Store Nord: Interim Report Q3 2017: Continued Solid Organic Revenue Growth Drives Strong EBITA Growth

  GN Store Nord delivered 7% organic revenue growth in Q3 2017. Revenue growth was 8% including impact from development in foreign exchange rates and M&A.

  November 2, 2017

   · 

  2 min read
• Pharm Country

  Blackfynn Extends Position As The Leading Data Platform For Neuroscience Through Funding, Partnerships, Product Launch And Team

  Blackfynn has announced a series of new partnerships, funding, strategic initiatives and team members that extend its position as the leading data platform for neuroscience and neurology.

  November 2, 2017

   · 

  6 min read
• Business

  Bioblast Pharma Reports Third Quarter 2017 Financial Results

  The company announced financial results for the third quarter ended September 30, 2017.

  November 2, 2017

   · 

  6 min read
• EKF Procalcitonin Assay FDA Cleared and Validated for Beckman AU Chemistry Analyzers

  EKF is pleased to confirm the immediate availability of a user defined application (UDA) for running this 10 minute test for bacterial infection and sepsis on these Beckman AU analyzers

  November 2, 2017

   · 

  3 min read